Registro completo de metadatos
Campo DC | Valor | Lengua/Idioma |
---|---|---|
dc.creator | Garcia-Quetglas, E. (Emilio) | - |
dc.creator | Azanza, J.R. (José Ramón) | - |
dc.creator | Sadaba, B. (Belén) | - |
dc.creator | Gil-Aldea, I. (I.) | - |
dc.date.accessioned | 2013-01-02T09:17:31Z | - |
dc.date.available | 2013-01-02T09:17:31Z | - |
dc.date.issued | 2003 | - |
dc.identifier.citation | Garcia Quetglas E, Azanza Perea JR, Sadaba Diaz de Rada B, Gil Aldea I. Farmacología de antimicrobianos utilizados en el tratamiento de las infecciones graves por bacterias grampositivas. Rev Esp Quimioter 2003 Sep;16(3):277-288. | es_ES |
dc.identifier.issn | 0214-3429 | - |
dc.identifier.uri | https://hdl.handle.net/10171/27543 | - |
dc.description.abstract | Antimicrobials with specific activity against Gram-positive cocci (glycopeptides, oxazolidinones and streptogramins) have pharmacokinetic differences that are important to know. Linezolid and teicoplanin can be administered extravascularly due to their good bioavailability, allowing their use as sequential therapy in patients requiring prolonged treatment. All of these antimicrobials have an adequate distribution in extracellular tissues, even teicoplanin, due to the balance between the fraction that is bound and unbound to plasma proteins and its long terminal half-life. As the elimination of glycopeptides is almost exclusively renal, it is necessary to perform a posology adjustment in patients with renal failure. Quinupristin/dalfopristin and linezolid are metabolized by the liver, but CYP450 is only involved in streptogramin elimination | es_ES |
dc.language.iso | spa | es_ES |
dc.publisher | Sociedad Española de Quimioterapia | es_ES |
dc.rights | info:eu-repo/semantics/openAccess | es_ES |
dc.subject | Anti-Bacterial Agents/blood/pharmacology/therapeutic use | es_ES |
dc.subject | Dose-Response Relationship, Drug | es_ES |
dc.subject | Gram-Positive Bacterial Infections/drug therapy | es_ES |
dc.title | Farmacología de antimicrobianos utilizados en el tratamiento de las infecciones graves por bacterias grampositivas | es_ES |
dc.type | info:eu-repo/semantics/article | es_ES |
dc.relation.publisherversion | http://www.seq.es/seq/0214-3429/16/3/277.pdf | es_ES |
dc.type.driver | info:eu-repo/semantics/article | es_ES |
Ficheros en este ítem:
Estadísticas e impacto
Los ítems de Dadun están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.